Biogena takes 13.7% stake in insect-protein petcare maker Herosan
What's the deal? Austria's Biogena GroupDealroom has a profile for this one. Try Dealroom → has acquired a 13.7% stake in Styrian company Herosan PetcareDealroom has a profile for this one. Try Dealroom →, the two firms announced on LinkedIn on August 20. Herosan joins existing partner ReploidDealroom has a profile for this one. Try Dealroom → as a shareholder.
What each company does: Herosan Petcare, founded in 2019 and based in Neutillmitsch, Styria, makes complete pet foods based on insect protein under its EntoVital brand for dogs and cats. It also produces supplementary feeds and CBD products from hemp grown on its own farms, selling mainly through vets and veterinary naturopaths.
Who's buying? The Salzburg-based Biogena GroupDealroom has a profile for this one. Try Dealroom →, founded in 2006, produces food supplements for human consumption and already works in animal health through Biogena PetsDealroom has a profile for this one. Try Dealroom →. Herosan employs between 11 and 50 staff, according to its LinkedIn profile.
Why now? Company founder and chief executive officer Albert Schmidbauer attributes the move to a shared approach of taking a holistic view of health, linking Biogena's human supplements business with Herosan's animal nutrition focus.
The signal: The deal points to growing investor interest in insect-protein pet nutrition, a niche drawing wider capital — French producer Innovafeed recently secured €51 million. Biogena's minority stake gives it exposure to the segment without a full buyout.
Read more: petworldwide.net
Image credit: Mr.TinDC
